Get the Stockscreener App
3.69
0.82%
0.03
After Hours:
3.69
Immucell Corp stock is traded at $3.69, with a volume of 24,911.
It is up +0.82% in the last 24 hours and up +2.22% over the past month.
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
See More
Previous Close:
$3.66
Open:
$3.7
24h Volume:
24,911
Relative Volume:
0.69
Market Cap:
$28.90M
Revenue:
$23.84M
Net Income/Loss:
$-3.81M
P/E Ratio:
-4.7922
EPS:
-0.77
Net Cash Flow:
$-713.00K
1W Performance:
+2.22%
1M Performance:
+2.22%
6M Performance:
-21.66%
1Y Performance:
-19.26%
1-Day Range:
$3.65
$3.75
1-Week Range:
$3.40
$3.76
52-Week Range:
$3.34
$5.59
Immucell Corp Stock (ICCC) Company Profile
Name
Immucell Corp
Sector
Industry
Phone
(207) 878-2770
Address
56 EVERGREEN DR, PORTLAND, ME
Compare ICCC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| ICCC | 3.69 | 28.90M | 23.84M | -3.81M | -713.00K | -0.77 |
| VRTX | 450.97 | 116.14B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 738.00 | 81.10B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 605.92 | 36.23B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 244.89 | 31.59B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 113.13 | 27.12B | 3.30B | -501.07M | 1.03B | 11.54 |
Immucell Corp Stock (ICCC) Latest News
ImmuCell Q3 Earnings Decline Y/Y, Sales Grow Amid Margin Challenges - MSN
ImmuCell Third Quarter 2024 Earnings: US$0.086 loss per share (vs US$0.12 loss in 3Q 2023) - Yahoo Finance
ImmuCell Corporation (NASDAQ:ICCC) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: ImmuCell reports recovery and strong demand for Q3 2024 - Investing.com
ICCCImmucell Corp Latest Stock News & Market Updates - StockTitan
ImmuCell Q3 Sales Jump 11% to $6M, Nine-Month Revenue Surges 51% Despite Net Loss | ICCC Stock News - StockTitan
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024 - StockTitan
ImmuCell reports 11% sales boost in third quarter - Investing.com
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2024 - StockTitan
ImmuCell amends lease terms and by-laws - Investing.com
Healthcare Stock Performance - Yahoo Finance
IMMUCELL CORP- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com
ImmuCell Second Quarter 2024 Earnings: US$0.20 loss per share (vs US$0.18 loss in 2Q 2023) - Yahoo Finance
ImmuCell Corporation (NASDAQ:ICCC) Q2 2024 Earnings Call Transcript - Insider Monkey
Earnings call: ImmuCell reports growth amid operational challenges - Investing.com
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2024 - StockTitan
ImmuCell (ICCC) Scheduled to Post Earnings on Wednesday - Defense World
ImmuCell stock touches 52-week low at $3.92 amid market challenges - Investing.com
ImmuCell Corp hits 52-week low, trading at $4.05 - Investing.com
PriceSmart, Kura Sushi And 3 Stocks To Watch Heading Into Wednesday - Benzinga
ImmuCell reports robust sales growth in Q2 2024 - Investing.com
ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2024 - StockTitan
ImmuCell (NASDAQ:ICCC) Stock Price Crosses Below Two Hundred Day Moving Average of $4.95 - Defense World
ImmuCell says Pfizer terminates contract on Mast Out - Reuters.com
Short Interest in ImmuCell Co. (NASDAQ:ICCC) Expands By 66.7% - Defense World
Rollins (NYSE:ROL) Upgraded to “Buy” at StockNews.com - Defense World
VBI Vaccines (NASDAQ:VBIV) Now Covered by Analysts at StockNews.com - Defense World
Immucell updates status of product development initiative for Re-TainTipRanks.com - TipRanks
ImmuCell progresses with FDA regulatory process for cattle health product By Investing.com - Investing.com Australia
ImmuCell Provides Update on Regulatory Status of Product Development Initiative for Re-Tain® - GlobeNewswire Inc.
ImmuCell progresses with FDA regulatory process for cattle health product - Investing.com
ImmuCell Corporation (NASDAQ:ICCC) Q1 2024 Earnings Call Transcript - Insider Monkey
Earnings call: ImmuCell reports sales increase to $7.2 million - Investing.com South Africa
Earnings call: ImmuCell reports sales increase to $7.2 million By Investing.com - Investing.com UK
ImmuCell Corporation (ICCC) Q1 2024 Earnings Call Transcript - Seeking Alpha
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024 - Investing.com India
3 Magnificent S&P 500 Dividend Stocks Down 17% to 44% to Buy and Hold Forever - The Motley Fool
After-hours movers: SMART Global, PriceSmart, and more By Investing.com - Investing.com
Breeding innovation: Rarebreed grows out of Maine’s animal-health hub - Mainebiz
Bovine Mastitis Treatment System Market Analysis : US, Germany, France, India, ChinaForecast 2024-2028 - Technavio
Top 20 Animal Health Companies in the World - Insider Monkey
Today's Gap Up Stocks | Find Top Stocks Gapping Up Today - MarketBeat
‘Unleashing’ growth: Maine's emerging ‘Silicon Valley for animal health’ - Mainebiz
Democrat Jacky Rosen sees Big Pharma investments soar while urging lower drug prices - Washington Examiner
ImmuCell achieves USDA approval of new product claim - Feedstuffs
Jim Grasky named to senior role at Olympia Snowe Women's Leadership Institute - Press Herald
No. 1 in the Northeast: Maine startup business is region’s fastest-growing, says Inc. - Press Herald
UMass Amherst Allows Maine-based ImmuCell Corp. the Right to License New Bacteriocin Technology - UMass News and Media Relations
Biotechnology now employs nearly 10,000 workers in Maine - Press Herald
ImmuCell plans second expansion in three years as demand grows - Mainebiz
Portland-based biotech ImmuCell posts 45% sales increase for Q4 - Mainebiz
Immucell Corp Stock (ICCC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.89%
2.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):